
7 Peptides Face FDA Review in July 2026. Is Your Practice Exposed?
On June 29, 2026, the FDA’s career scientists posted briefing documents for the upcoming Pharmacy Compounding Advisory Committee (PCAC) meeting scheduled for July 23 and 24. In each document, the agency recommended against easing restrictions on the peptides under review, concluding there was not enough

















